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Background: As breast cancer patients increasingly use complementary and alternative medicine (CAM), clinical trials
are needed to guide appropriate clinical use. We sought to identify socio-demographic, clinical and psychological
factors related to willingness to participate (WTP) and to determine barriers to participation in an acupuncture clinical
trial among breast cancer patients.
Methods: We conducted a cross-sectional survey study among post-menopausal women with stage I-III breast cancer
on aromatase inhibitors at an urban academic cancer center.
Results: Of the 300 participants (92% response rate), 148 (49.8%) reported WTP in an acupuncture clinical trial. Higher
education (p = 0.001), increased acupuncture expectancy (p < 0.001), and previous radiation therapy (p = 0.004) were
significantly associated with WTP. Travel difficulty (p = 0.002), concern with experimentation (p = 0.013), and lack of
interest in acupuncture (p < 0.001) were significant barriers to WTP. Barriers differed significantly by socio-demographic
factors with white people more likely to endorse travel difficulty (p = 0.018) and non-white people more likely to report
concern with experimentation (p = 0.024). Older patients and those with lower education were more likely to report
concern with experimentation and lack of interest in acupuncture (p < 0.05).
Conclusions: Although nearly half of the respondents reported WTP, significant barriers to participation exist and differ
among subgroups. Research addressing these barriers is needed to ensure effective accrual and improve the
representation of individuals from diverse backgrounds.
Keywords: Acupuncture, Breast neoplasm, Clinical trial, Aromatase inhibitors/*adverse effects, Musculoskeletal,
Joint pain, Attitudes, BarriersBackground
This year, an estimated 226,870 women will be diagnosed
with breast cancer and most of them will join the 2.6 mil-
lion breast cancer patients living in the United States [1].
Due to the extensive symptom distress experienced by this
population and many women’s desire for natural ap-
proaches, many breast cancer patients use complementary
and alternative medicine (CAM) [2-6]. Further, women
may also turn to CAM therapies, as data suggests that these* Correspondence: jun.mao@uphs.upenn.edu
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reproduction in any medium, provided the ortherapies may help patients ameliorate the side effects of
treatment and the late effects of their disease [7-10]. Data
suggests that the rates of CAM use have increased among
women with breast cancer in recent years to as high as 84%
[11-15].
In order to guide evidence-based use of CAM for breast
cancer patients, clinical trials are needed to evaluate the
safety, efficacy and effectiveness of these potential therapies,
in particular, for symptom management. Effective recruit-
ment to clinical trials is critical to the successful execution
of trials; however about 38% of cancer clinical trials (CCT)
fail to meet minimum accrual goals [16]. Further, 80% of
trials are unable to achieve accrual goals within the antici-
pated recruitment period and remain open longer thand. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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delivery of scientific findings to patients and clinicians
[17,18].
Annually, very few adult cancer patients participate in
CCTs, and racial/ethnic minorities are often underrep-
resented in CCTs [19]. Studies have shown that factors
influencing participation in CCTs include participant
demographics, insurance coverage, awareness of CCTs,
potential side-effects of the CCT, trial setting, concern
with the research process, complexity and stringency of
the research protocol, and physician attitudes towards
the trial [20-24]. Research examining accrual to CAM
trials among breast cancer patients is extremely limited
with only one study investigating factors affecting par-
ticipation in a mind-body trial, which reported that 30%
of its participants consented to participate in a CAM
clinical trial [25]. Furthermore, few studies have examined
participation, specifically, in symptom management trials.
Instead, most aggregate total trial participation or focus
on participation in therapeutic CCTs [19,21,26,27]. As
Agrawal et al. found that fear of cancer growth is often the
primary reason for clinical trial participation, it is clear
that there may be differences in attitudes and barriers to
trial participation between therapeutic and symptom man-
agement CCTs [28].
A better understanding of factors that affect participa-
tion in CAM CCTs is critically important for planning and
executing successful investigations and ensuring adequate
representation from historically underrepresented groups
of individuals into these trials. Many of the CAM inter-
ventions such as acupuncture require weekly or, even
more often, interventions over several weeks or months,
thus the burden on potential research subjects from trial
participation can be greater than conventional CCTs. In
addition, most research to date has focused on studying
enrollment towards CCTs for treatment of cancer, which
may differ from CAM trials as CAM is often used for
symptom management. Thus, we conducted this study to
(1) identify the attitudes and barriers towards willingness
to participate (WTP) in an acupuncture trial for joint pain
among breast cancer patients; (2) determine the demo-
graphic, clinical, and psychological variables that may be
predictive of WTP, and (3) elucidate the relationship be-
tween socio-demographic variables and perceived barriers
to trial participation.
We chose acupuncture as the modality of focus be-
cause in a review of large U.S. comprehensive cancer
center websites, Brauer et al. found that 60% of web-
sites supported acupuncture as a means for symptom
management in cancer; thus this therapy shows great
promise for integration into conventional cancer care [29].
In addition, a population-based study found that cancer
patients use acupuncture at a greater rate than non-cancer
controls (10.2 vs. 6.2, p < 0.001) [2]. Aromatase-inhibitor(AI) related arthralgia was chosen as a symptom to focus
on because we found that it affects close to 50% of women
who take AI as adjuvant therapy for breast cancer [30].
Methods
Study design and patient population
We conducted a cross-sectional survey of breast cancer
patients receiving care at the Rena Rowan Breast Center
at the Abramson Cancer Center of the University of
Pennsylvania (Philadelphia, PA) between April and October
2007 as part of a larger cohort study that is ongoing. Poten-
tial participants included all postmenopausal women with a
history of histologically confirmed stage I to III, hormone-
receptor-positive breast cancer who were currently taking a
third-generation AIs (anastrozole, letrozole, or exemestane),
had completed chemotherapy or radiotherapy at least one
month prior to enrollment, and had the ability to under-
stand and provide informed consent in English. Research
assistants obtained permission from the treating oncologist,
screened medical records and approached potential study
subjects for enrollment at their regular follow-up ap-
pointments. After informed consent was obtained, each
participant was given a self-administered survey. The
study was approved by the Institutional Review Board of
the University of Pennsylvania and the Scientific Review
and Monitoring Committee of the Abramson Cancer
Center.
Survey instrument
The primary outcome measure was WTP in an acupunc-
ture clinical trial among breast cancer patients with AI-
related arthralgia. Participants were presented with a de-
scription of the study, “We are interested in performing
an acupuncture study for joint pain among breast cancer
patients receiving aromatase inhibitors. It will require up
to 8–10 treatments over the course of 6–8 weeks. Each
treatment lasts about 20 to 45 minutes. Acupuncture will
be performed by a licensed acupuncturist. You will be
compensated at the end of the study for your time and
travel.” This was followed by a hypothetical question,
“How likely are you to participate in an acupuncture trial,
should you have daily bothersome joint pain?” Response
options included “very much,” “somewhat,” “a little,” and
“not at all.”
To assess the theoretical barriers to participation, partici-
pants were asked how much they agreed to statements re-
garding barriers to participation. These barriers were
identified during focus group interviews, as well as from
previous literature regarding CAM clinical trial recruitment
[25,31-34]. Barriers surveyed included: travel difficulty, con-
cern with experimentation (“I find it difficult to participate
in an acupuncture study because I don’t want to be ‘experi-
mented’ on”), presence of placebo group (“I find it difficult
to participate in an acupuncture study because I don’t want
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sponsibilities, and lack of interest in acupuncture. Partici-
pants chose from “strongly disagree,” “disagree,” “not sure,”
“agree,” and “strongly agree.” We piloted the instrument be-
fore administration of the survey.
We also used the Acupuncture Expectancy Scale (AES), a
validated instrument to measure outcome expectancy re-
lated to acupuncture, as belief in acupuncture may affect
WTP in an acupuncture trial [35,36]. AES was previously
validated in breast cancer patients with scores ranging from
4 to 20 with higher score indicating greater outcome ex-
pectancy. The internal consistency of the scale (Cronbach’s
alpha coefficient) was 0.95 [36]. Other covariates measured
included socio-demographic variables (i.e. age, race/ethni-
city, education level, and employment status), and clinical
and psychological factors (i.e. prior CAM use and severity
of joint pain in the past 7 days), which were collected
through self report. Clinical and treatment characteristics
were also assessed by medical record abstraction (i.e. stage
of breast cancer, previous surgery, previous chemotherapy,
and previous radiotherapy). Traveling distance was calcu-
lated using Google Maps between home residence and hos-
pital location.
Statistical analysis
All data was entered by research assistants with verifica-
tion by a separate data manager. Less than 5% of the data
was missing in all of the key variables described in the
paper. Missing data was treated as missing. Data analysis
was performed using STATA 12.0 for Windows (STATA
Corporation, College Station, TX). For WTP, we coded re-
sponses of “somewhat,” and “very much” to the question,
“How likely are you to participate in an acupuncture trial,
should you have daily bothersome joint pain?” Participants
who selected “not at all” and “a little” were coded as not
WTP. We chose to dichotomize this outcome to ease the
interpretation of the data because the actual clinical trial
participation is a dichotomous decision “yes” and “no.”
This dichotomous variable was used as the main outcome
in both bivariate and multivariate analyses. For the barriers
to participation, we coded participants who “agree” and
“strongly agree” to the barriers as endorsing the barriers.
We initially computed descriptive statistics for all items.
We then performed chi-square analyses to determine the
relationship between WTP, relevant covariates (e.g. age,
education, and race/ethnicity) and specific barriers. We
also performed chi-square analyses to evaluate the rela-
tionship between key socio-demographic factors (i.e. age,
race/ethnicity, and education status) and specific barriers.
We then built multivariate logistic regression models in
three steps with WTP as the dependent variable. Variables
that were associated with the WTP at the significance level
less than 0.10 in bivariate analyses were included. In
Model 1, we sought to identify the demographic, clinical,and psychological factors related to WTP. In Model 2, we
aimed to identify the barriers related to WTP. In Model 3,
we incorporated factors that were significant in both
models 1 and 2. Further, since joint pain may impact
WTP, we repeated Model 3 analyses restricting only to
those with current joint symptoms. All analyses were two-
sided with p-value less than 0.05 indicating significance.
Results
Patient characteristics
As previously reported, 300 (92% of eligible patients) par-
ticipated in this study [30]. Among those who declined
participation (N = 25), common reasons were lack of time,
not feeling well, and did not want to participate in re-
search. Among the study participants, the mean age was
61.5 (SD = 9.9). The majority of the participants were non-
Hispanic white people (84.3%) and a substantial proportion
of non-Hispanic black (12.7%). Educational status varied
among the participants: 40.7% had a high school level edu-
cation or less, 25.6% had college-level education, and 33.7%
had graduate or professional school level education. Other
characteristics of the study participants can be seen in
Table 1.
Socio-demographic, clinical, and psychological factors
related to WTP
Among 300 participants, 148 (49.8%) were willing to par-
ticipate in an acupuncture clinical trial. In the bivariate
analysis, younger age, higher education, presence of co-
morbidities, severe joint pain in the past 7 days and
greater acupuncture expectancy were significantly associ-
ated with greater WTP (see Table 1). While stage of can-
cer, previous chemotherapy, and type of AI were not
significantly related, previous radiation therapy and CAM
use were significantly associated with greater WTP.
Barriers to participating in an acupuncture trial
The most common barriers toward participation included
presence of placebo group (45.9%), travel difficulty
(45.6%), and home responsibilities (45%) followed by de-
manding job (35.6%), lack of interest in acupuncture
(27.2%), and concern with experimentation (25.2%). In the
bivariate analysis, all barriers but demanding job were sig-
nificantly associated with WTP (p < 0.05) (see Figure 1).
Specific barriers to trial participation differed signifi-
cantly across several key socio-demographic subgroups
(see Table 2). In the bivariate analysis, older breast cancer
patients were more likely to cite concern with experimen-
tation (p < 0.001) and lack of interest in acupuncture (p =
0.008) as barriers toward trial participation, while younger
women were more likely to cite demanding job (p < 0.001)
and home responsibilities (p = 0.003) as barriers to participa-
tion. Similarly, employed women were more likely to con-
sider demanding job (p < 0.001) and home responsibilities
Table 1 Demographic and clinical characteristics of
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Abbreviations: AI, Aromatase Inhibitor; CAM, complementary and
alternative medicine.
*P-value obtained by Chi-2 for categorical and T-test for continuous outcomes.
Not all cells add up to 300 due to missing data.
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cated women were more likely to consider concern with ex-
perimentation (p < 0.001), presence of placebo group (p =
0.005), and lack of interest in acupuncture (p = 0.001) as
barriers to participation. Non-white women were more
likely to consider concern with experimentation (p = 0.024)
a barrier to participation. However, white women were more
likely to cite travel difficulty (p = 0.018) as a barrier to par-
ticipation. Among the survey participants, fewer white
women lived within 10 miles of the hospital (17.8%) com-
pared with non-white women (68.1%), (p < 0.001).Multivariate analyses: factors related to WTP
In multivariate analyses adjusting for socio-demographic
and clinical factors and self-reported barriers (Model 3
in Table 3), we found that college level education (ad-
justed odds ratio [AOR], 4.24, 95% confidence interval
[CI], 1.77-10.17, p = 0.001), previous radiation therapy
(AOR, 2.72, 95% CI, 1.39-5.32, p = 0.004), and a higher
score on the Acupuncture Expectancy Scale (AOR, 1.17,
95% CI, 1.08-1.26, p < 0.001) were significantly associ-
ated with increased likelihood to report WTP, while en-
dorsement of travel difficulty (AOR, 0.36, 95% CI, 0.19-
0.68, p = 0.002), lack of interest in acupuncture (AOR,
0.12, 95% CI, 0.04-0.35, p < 0.001) and concern with ex-
perimentation (AOR, 0.31, 95% CI, 0.13-0.78, p = 0.013)
were barriers independently associated with decreased
likelihood of participation. In a sub-analyses restricting to
only those patients with current joint symptoms, we found
very similar results. College education (AOR, 4.22, p =
0.003), previous radiation therapy (AOR, 2.39, p = 0.019),
and higher expectancy (AOR, 1.16, p = 0.001) were signifi-
cantly associated with greater WTP in acupuncture stud-
ies, while travel difficulty (AOR, 0.35, p = 0.003), concerns
about experimentation (AOR, 0.34, p = 0.035), and lack of
interest in acupuncture (AOR, 0.12, p = 0.001) were asso-







































Not willing to participate
Figure 1 Barriers to participation differ by willingness to participate. *P < 0.001 by chi square analyses.
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In this study, approximately one in two breast cancer pa-
tients were willing to participate in an acupuncture clinical
trial for arthralgia. This figure is greater than WTP to gen-
eral CCTs, which has been reported to range from 3% to
33% [19,26,37]. The most common barriers to participa-
tion in an acupuncture trial were travel difficulty, demand-
ing jobs and home responsibilities, and concern with
experimentation. Importantly, specific barriers differed by
socio-demographic groups. Adjusting for relevant covari-
ates, college education, previous radiation therapy, and
higher expectancy of acupuncture outcomes were signifi-







N % p-value N % p-value N % p
Age 0.90 <0.001
≤55 34 47.9 13 18.3 29 40.9
56-65 58 45.0 23 18.1 53 41.4
>65 42 44.7 37 40.2 52 55.9
Race 0.018 0.024
White 120 48.6 55 22.6 109 44.5
Non-White 14 29.8 18 38.3 25 53.2
Education 0.54 <0.001
High school** 59 48.8 49 40.8 68 56.2
College 30 40.5 9 12.3 24 32.9
Graduate 45 45.9 15 15.6 42 43.3
Employment 0.24 0.037
Full-time 53 48.2 21 19.1 45 40.9
Part-time 21 53.9 6 15.8 14 35.9
Not currently 57 40.4 43 31.2 72 51.8
*Bivariate chi-square analysis.
**High school or less.identified barriers that were independently associated with
decreased participation including travel difficulty, concern
with experimentation, and lack of interest in acupuncture.
These findings have implications for designing and execut-
ing acupuncture symptom management clinical trials to
ensure timely and adequate accrual with sufficient repre-
sentation of trial participants from diverse groups.
We found that those patients with a college education
were more likely to report greater WTP in an acupuncture
trial than those with high school or less education. Prior
studies have indicated that higher education was related to
both greater CAM use and more WTP in conventional







-value N % p-value N % p-value N % p- value
0.063 <0.001 0.003 0.008
42 59.2 44 62.0 14 19.4
46 36.5 54 42.5 30 23.1
15 16.3 33 35.5 37 38.5
0.27 0.42 0.96 0.43
89 36.6 110 45.1 66 26.3
14 30.4 21 44.7 15 31.9
0.005 0.18 0.40 0.001
35 29.7 57 47.5 47 38.5
28 38.4 28 38.4 15 19.7
40 41.2 46 47.4 19 19.2
0.100 <0.001 0.031 0.17
79 71.2 59 53.2 27 23.9
13 33.3 20 51.3 15 38.5
10 7.4 51 37.2 35 24.7
Table 3 Factors related to willingness to participate: multivariate analysis
Model 1* Model 2+ Model 3++
Bivariate analysis Multivariate analysis Multivariate analysis Multivariate analysis
Pseudo R2 = 0.20 Pseudo R2 = 0.25 Pseudo R2 = 0.36
O.R. (95% C.I.) p-value A.O.R. (95% C.I.) p-value A.O.R. (95% C.I.) p-value A.O.R. (95% C.I.) p-value
Age
≤55 1 1
56-65 0.67 (0.37-1.21) 0.18 0.77 (0.38-1.58) 0.48
>65 0.44 (0.24-0.83) 0.011 0.85 (0.40-1.83) 0.68
Education
High school or less 1 1 1
College 4.18 (2.26-7.73) <0.001 4.07 (1.97-8.42) <0.001 4.24 (1.77-10.17) 0.001
Graduate 1.93 (1.12-3.31) 0.018 1.86 (0.97-3.56) 0.062 1.27 (0.62-2.61) 0.51
Radiation therapy
No 1 1 1
Yes 1.79 (1.10-2.89) 0.017 2.09 (1.16-3.76) 0.014 2.72 (1.39-5.32) 0.004
CAM use
No 1 1
Yes 2.36 (1.46-3.82) <0.001 1.26 (0.71-2.24) 0.43
Joint pain during past 7 days
None 1 1 1
Mild/moderate 1.98 (1.06-3.71) 0.032 2.06 (0.96-4.44) 0.064 1.48 (0.61-3.57) 0.38
Severe or more 2.60 (1.19-5.67) 0.017 3.49 (1.34-9.04) 0.01 2.77 (0.89-8.59) 0.078
Co-morbidity
No 1 1
Yes 0.58 (0.35-0.97) 0.038 0.65 (0.34-1.23) 0.19
Acupuncture expectancy scale 1.19 (1.12-1.26) <0.001 1.20 (1.12-1.28) <0.001 1.17 (1.08-1.26) <0.001
Travel difficulty
Disagree 1 1 1
Agree 0.27 (0.16-0.44) <0.001 0.41 (0.23-0.75) 0.003 0.36 (0.19-0.68) 0.002
Concern with experimentation
Disagree 1 1 1
Agree 0.13 (0.069-0.26) <0.001 0.34 (0.14-0.81) 0.015 0.31 (0.13-0.78) 0.013
Don't want placebo
Disagree 1 1
Agree 0.40 (0.24-0.64) <0.001 0.96 (0.50-1.83) 0.90
Demanding job
Disagree 1 1
Agree 0.73 (0.45-1.18) 0.196 1.10 (0.58-2.09) 0.77
Home responsibilities
Disagree 1 1
Agree 0.39 (0.24-0.62) <0.001 0.77 (0.41-1.42) 0.40
Not interested in acupuncture
Disagree 1 1
Agree 0.051(0.022-0.12) <0.001 0.098 (0.040-0.24) <0.001 0.12 (0.043-0.35) <0.001
*Model 1: Multivariate analysis on sociodemographic and clinical factors related to willingness to participate.
+Model 2: Multivariate analysis on barriers related to willingness to participate.
++Model 3: Multivariate analysis on factors significant in Model 2 and 3 related to willingness to participate.
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that those with lower education were more likely to cite
barriers such as concern with experimentation, presence
of placebo, and lack of interest in acupuncture. To some
degree, these factors may reflect lack of literacy regarding
clinical trials and/or acupuncture; however, in multivariate
models adjusting for these barriers, education was still
highly associated with minimal change in adjusted odds
ratio. These suggest factors related to education but not
accounted for by these barriers, such as social support and
income, may explain some of the association and warrant
further investigation.
Higher expectancy of acupuncture outcomes for relief of
arthralgia symptoms was associated with greater WTP in
an acupuncture clinical trial. Although previous studies
have investigated the association between expectancy and
treatment outcome, to our knowledge, no prior studies
have examined the relationship between outcome expect-
ancy and WTP [38]. While clinical trials are meant to in-
form care delivery for future patients, it is not surprising
that individuals who are interested in participating in a clin-
ical trial do so in part with the hope that their specific con-
ditions will be improved by trial participation. Given that
previous research also found that higher expectancy of acu-
puncture outcomes may impact response to acupuncture,
future clinical trials should include validated expectancy
measures to help understand how expectancy may explain
the variability observed in different studies [35,38-41].
Previous research has identified many barriers that
present significant obstacles to accrual in conventional
CCTs [21,23,31,34]. Our study not only identified barriers
but also examined the how these barriers differed by spe-
cific socio-demographic factors, thereby identifying bar-
riers to participation in symptom management trials. Our
findings of ‘concern with experimentation’ and ‘travel diffi-
culty’ as barriers to participation are similar to a recent
meta-analysis by Mills et al. [21]. Non-white people, espe-
cially African Americans were significantly more likely
than white people to cite concern with experimentation as
a barrier, which indicates discomfort with the experimen-
tation process [42,43]. This may be due to historical re-
search abuses of blacks and the persistence of health
inequities experienced by racial minorities [34,42,43].
Conversely, we found more white people reported travel
difficulty as a barrier. This is likely due to the racial differ-
ences in geographic distance between a patient’s residence
and the hospital among our study population. We found
that more white people in our study lived farther away
from the hospital, while more non-white people lived
within a 10-mile radius. This is logical as the Hospital of
the University of Pennsylvania is an inner city hospital sur-
rounded by neighborhoods in which low income groups
and minorities predominate. Our findings suggest that
unique challenges to trial enrollment exist and differentstrategies are required to overcome barriers experienced
by individuals of diverse socio-demographic groups.
There are a number of limitations that should be consid-
ered in the interpretation of our results. This study only
examined hypothetical WTP in an acupuncture clinical
trial. It is possible that these findings may not translate into
actual clinical trial participation. Additionally, research
using more sophisticated methods such as conjoint ana-
lyses may help better elucidate the complex decision mak-
ing involved in trade-offs about different factors that drive
patients’ willingness to enroll or not in a CAM trial. Our
study also focused on studying only acupuncture for a spe-
cific symptom and should not be over-interpreted for other
types of complementary and alternative medicine strategies.
Further, our study was conducted in an academic medical
center with majority of the participants being white which
may limit its generalizability to community settings. Finally,
African Americans were the predominant minority group
included in this study thus limiting generalization of find-
ings to other various vulnerable populations and racial
minorities.
Despite the limitations, our study provided a comprehen-
sive examination of factors associated with and barriers to-
wards WTP in an acupuncture clinical trial. Furthermore,
our study was unique in that it identified attitudes and bar-
riers towards participation in a symptom management
CCT. Previous studies mostly focused on studying partici-
pation in therapeutic cancer clinical trials. Thus our study
provided novel information on participation in symptom
management CCTs. As acupuncture and other mind-body
CAM interventions (e.g. yoga, meditation) often require
once or twice weekly interventions over multiple weeks, lo-
gistic issues such as traveling and competing responsibilities
at home/work become substantially more important for
these trials than the conventional CCT. Thus, having satel-
lite sites to deliver the interventions, offering interventions
at times that are convenient for participants, and offering
baby-sitting may be some strategies to improve accrual and
retention to these trials. Additionally, concerns about ex-
perimentation and lack of interest in acupuncture may be
mitigated by appropriate education of potential research
subjects about clinical trials and acupuncture, especially
among the less educated or racial minorities, so that ad-
equate representations from these groups can be achieved
in CAM trials.
Conclusions
We found that one in two breast cancer patients reported
willingness to participate in an acupuncture trial for arth-
ralgia. It is encouraging that a large proportion of patients
are willing to participate in an acupuncture trial for symp-
tom management which indicates acupuncture having
clinical relevance in this population. Our findings of socio-
demographic factors related to barriers will further allow
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http://www.biomedcentral.com/1472-6882/14/7researchers to strategically address the specific barriers
faced by patients and ensure adequate representation in
trials by individuals from historically underrepresented
groups. With carefully designed and well-executed clinical
trials, we can move towards an evidence-based integration
of acupuncture for symptom management in cancer for
individuals from diverse backgrounds.
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